Sanders calls on FDA to allow low-cost rivals to $375k Catalyst drug

US Senator Bernie Sanders says the FDA should allow pharmacies and generic manufacturers to make low-cost copies of Catalyst Pharma’s rare disease drug Firdapse, which is at the heart of a pricing scandal.